Anders Helander (A Helander)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 19

Top Venues

Drug testing and analysis

Scandinavian journal of clinical and laboratory investigation

Clinical toxicology (Philadelphia, Pa.)

Journal of mass spectrometry : JMS

Karolinska Institutet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet

Sweden

Adj professor :: Laboratory Medicine

Publications

Anders Helander, Annika Andersson, Tomas Villén
Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023. Drug testing and analysis (2024)
Anders Helander, Malin Johansson, Tomas Villén, Annika Andersson
Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing - focus on HHC, HHC-P, HHC-O and HHC-H. Scandinavian journal of clinical and laboratory investigation 84 (2) (2024)
Anders Helander, Malin Johansson, Tomas Villén, Annika Andersson
Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing - focus on HHC, HHC-P, HHC-O and HHC-H. Scandinavian journal of clinical and laboratory investigation (2024)
Anders Helander, Tomas Villén, Patrick Signell
Urine Drug Tests Indicate Higher Prevalence of Combined Alcohol and Cocaine Use Compared to Alcohol Together with Cannabis or Amphetamine-A Possible Link to Cocaethylene. Alcohol and alcoholism (Oxford, Oxfordshire) (2023)
Anders Helander, Therese Hansson
The alcohol biomarker phosphatidylethanol (PEth) - test performance and experiences from routine analysis and external quality assessment. Scandinavian journal of clinical and laboratory investigation (2023)
Frank Musshoff, Michael Böttcher, Matthias Graw, Gisela Skopp, Jasna Neumann, Gudrun Høiseth, Anders Helander
Comment on the upper cutoff level for the alcohol biomarker phosphatidylethanol (PEth) for the assessment of alcohol consumption in forensic practice. Drug testing and analysis (2022)
Anders Helander, Alexia Rylski
Drug testing for mitragynine and kratom: Analytical challenges and medico-legal considerations. Drug testing and analysis (2022)
Olof Beck, Maria Mellring, Christian Löwbeer, Sabina Seferaj, Anders Helander
Measurement of the alcohol biomarker phosphatidylethanol (PEth) in dried blood spots and venous blood-importance of inhibition of post-sampling formation from ethanol. Analytical and bioanalytical chemistry 413 (22) (2021)
Anders Helander, Malin Johansson, Annika Andersson, Tomas Villén
Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): Results from urine drug testing in Sweden. Drug testing and analysis (2021)
Anders Helander, Matilda Bäckberg, Olof Beck
Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PloS one 15 (4) (2020)
Matilda Bäckberg, Madeleine Pettersson Bergstrand, Olof Beck, Anders Helander
Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project. Clinical toxicology (Philadelphia, Pa.) 57 (3) (2018)
Lisa Franzén, Olof Beck, Anders Helander
An analytically confirmed non-fatal intoxication by carfentanil in Sweden. Clinical toxicology (Philadelphia, Pa.) 57 (5) (2018)
Craig McKenzie, Oliver B Sutcliffe, Kevin D Read, Paul Scullion, Ola Epemolu, Daniel Fletcher, Anders Helander, Olof Beck, Alexia Rylski, Lysbeth H Antonides, Jennifer Riley, Shannah A Smith, Niamh Nic Daéid
Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users. Forensic toxicology 36 (2) (2018)
Anders Helander, Katarina Stojanovic, Tomas Villén, Olof Beck
Detectability of fentanyl and designer fentanyls in urine by 3 commercial fentanyl immunoassays. Drug testing and analysis (2018)
N N Stephanson, P Signell, Anders Helander, Olof Beck
Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing - a step towards a 'black-box' solution? Journal of mass spectrometry : JMS 52 (8) (2018)
Matilda Bäckberg, Karl-Henrik Jönsson, Olof Beck, Anders Helander
Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug testing and analysis 10 (2) (2017)
Olof Beck, Matilda Bäckberg, Patrick Signell, Anders Helander
Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clinical toxicology (Philadelphia, Pa.) 56 (4) (2017)
Madeleine Pettersson Bergstrand, Markus R Meyer, Olof Beck, Anders Helander
Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry. Drug testing and analysis 10 (3) (2017)
Anders Helander, M Bradley, A Hasselblad, L Norlén, I Vassilaki, M Bäckberg, J Lapins
Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45. The British journal of dermatology 176 (4) (2016)

Anders Helander.css-eqlu8i{font-size:small;padding-left:4px;} (A Helander)

Publication Activity (10 Years)

Top Topics

Top Venues

Anders Helander (A Helander)